A nurse is educating a newly licensed nurse about psychiatric pharmacogenomic testing. Which of the following statements by the newly licensed nurse Indicates an understanding of the teaching?
"Psychiatric pharmacogenomic testing allows providers to determine the likelihood that a treatment will produce a cure."
"Psychiatric pharmacogenomic testing provides health care providers with information about treatment interactions.
"Psychiatric pharmacogenomic testing allows providers to determine effective treatment modalities."
Psychiatric pharmacogenomic testing allows providers to determine the cause of mental illness based on genetics."
The Correct Answer is C
C. Psychiatric pharmacogenomic testing involves analyzing an individual's genetic makeup to predict their response to psychiatric medications. This testing provides healthcare providers with information about how an individual's genetic variations may impact their metabolism of medications.
A. Psychiatric pharmacogenomic testing can inform treatment decisions but it does not determine the likelihood of a cure. Mental illness is complex and often requires multimodal treatment approaches beyond medication alone.
B. Pharmacogenomic testing can provide information about how an individual's genetics may interact with specific medications but it primarily focuses on identifying which medications are likely to be most effective for the individual, rather than interactions between medications.
D. Psychiatric pharmacogenomic testing does not determine the cause of mental illness. Mental illnesses are multifactorial and have complex etiologies involving genetic, biological, environmental, and psychosocial factors.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A. Opioids are often prescribed for pain management, and individuals with chronic pain conditions may be at increased risk for developing opioid use disorder if they misuse or become dependent on these medications.
B. While opioids can have sedating effects and may be used by some individuals to promote sleep, it is less likely to be a primary reason for starting opioid use, especially in the context of other significant factors such as chronic pain and anxiety.
C. While exposure to parental substance use can contribute to an individual's risk of developing substance use disorders, there is no indication in the scenario provided that the client's parents used opioids specifically or that their parents' substance use directly influenced the client's opioid use.
D. Opioids are not typically used to treat hallucinations, and their use for performance enhancement in the workplace is uncommon.
Correct Answer is C
Explanation
C. Alzheimer's disease is a neurodegenerative disorder characterized by progressive cognitive decline, memory loss, and changes in behavior. Research suggests that individuals with
schizophrenia may have an increased risk of developing Alzheimer's disease compared to the general population.
A. Osteoarthritis is a degenerative joint disease primarily affecting older adults and is more closely linked to factors such as aging, joint injury, and obesity.
B. Diabetes mellitus is not associated with schizophrenia.
D. Cancer is not typically considered a comorbidity of schizophrenia. While individuals with schizophrenia may face certain health disparities and have higher rates of risk factors such as smoking, cancer itself is not directly linked to schizophrenia
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.